Maja Baretic
Overview
Explore the profile of Maja Baretic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
100
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jadresic M, Kusacic Kuna S, Tomic Brzac H, Baretic M, Huic D
Acta Clin Croat
. 2025 Jan;
62(4):585-594.
PMID: 39866755
Parathyroid cancer is an extremely rare malignancy that usually leads to hyperparathyroidism. The aim of this report is to present clinical and ultrasonographic features of tumors in six patients (5...
2.
3.
Baretic M, Primorac D, de Bruijn D, Altabas V
Medicina (Kaunas)
. 2024 Sep;
60(9).
PMID: 39336497
Technology is increasingly shaping human life, particularly in healthcare, where recent advancements have revolutionized patient care. Despite these advances, the World Health Organization's (WHO) definition of health remains rooted in...
4.
Baretic M, de Bruijn D
Monash Bioeth Rev
. 2024 Aug;
42(2):279-283.
PMID: 39143390
There are ethical dilemmas faced by clinicians when responding to using unregistered medical devices, such as innovative internet technologies for managing type 1 diabetes mellitus. This chronic disease significantly impacts...
5.
Kirigin Bilos L, Altabas V, Vukic Dugac A, Baretic M
Medicina (Kaunas)
. 2024 Mar;
60(3).
PMID: 38541202
Cystic fibrosis-related diabetes (CFRD) is the most common comorbidity in patients with cystic fibrosis (CF). CFRD has been correlated with important clinical outcomes, including poor nutrition, reduced pulmonary function, and...
6.
Baretic M, Leksic G, Ivanisevic M
Diabetes Spectr
. 2023 Nov;
36(4):373-378.
PMID: 38024224
The ambulatory glucose profile is a valuable tool in managing type 1 diabetes during pregnancy. Time in range (TIR) in the third trimester is one of the most significant parameters...
7.
Baretic M, Caban D, Sertic J
J Pers Med
. 2023 Jul;
13(7).
PMID: 37511676
Background: Mutation of the gene encoding Hepatocyte Nuclear transcription Factor-1 Beta (HNF1B) causes a rare monogenetic subtype of Maturity-Onset Diabetes of the Young (MODY). HNF1B-related MODY results in the dysfunction...
8.
Relative Frequency of Islet Autoimmunity in Children and Adolescents with Autoimmune Thyroid Disease
Putarek N, Krnic N, Knezevic-Cuca J, Kusec V, Baretic M, Dumic M
J Clin Res Pediatr Endocrinol
. 2023 Apr;
15(4):348-355.
PMID: 37074226
Objective: The aim of the present study was to investigate islet autoimmunity and susceptibility to type 1 diabetes (T1D) in children/adolescents with autoimmune thyroid disease (AITD, and in family members...
9.
Schuh A, Ayvaz G, Baldeschi L, Baretic M, Bechtold D, Boschi A, et al.
Br J Ophthalmol
. 2023 Jan;
108(2):294-300.
PMID: 36627174
Background: Graves' orbitopathy (GO) is subject to epidemiological and care-related changes. Aim of the survey was to identify trends in presentation of GO to the European Group On Graves' Orbitopathy...
10.
Vokurka Topljak S, Galiot Delic M, Mandic K, Peric S, Baretic M, Mandic J
Int Ophthalmol
. 2023 Jan;
43(7):2291-2299.
PMID: 36587368
Purpose: To evaluate the effectiveness of incobotulinumtoxinA (Xeomin) in treating upper eyelid retraction in patients with Graves orbitopathy (GO) initially scheduled for surgery via two different application sites. Methods: This...